logo-loader

Agenus Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$527.47 m
Price
3.84 USD
Change
0.26%
52 weeks high
4.57
52 weeks low
1.96

In brief

Agenus Inc., (Agenus), formerly Antigenics Inc., is a biotechnology company focused on the development and commercialization of technologies to treat cancers and infectious diseases, based on immunological approaches.